Keros Therapeutics (KROS) Non-Current Assets (2019 - 2026)
Keros Therapeutics' Non-Current Assets came in at $20.72 million for Q2 2026, down 14.9% from $24.36 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Keros Therapeutics' Non-Current Assets was $22.59 million, down 16.3% from FY2024.
- Non-Current Assets carries a five-year compound annual growth rate of 67.4% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $26.99 million in FY2024 (+18.7%), $22.73 million in FY2023 (+8.2%), $21.01 million in FY2022 (+451.4%) and $3.81 million in FY2021 (+122.0%).
- The Q2 2026 figure represents the lowest quarterly Non-Current Assets since Q3 2022.
- Year-over-year, Non-Current Assets increased in four of the last seven quarters, with growth averaging 2.6%.
- The fastest year-over-year change in Non-Current Assets over five years came in Q1 2023 (growth of 466.4%), and the weakest in Q4 2025 (a decline of 16.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.34 Bn | 1,100.93 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 615.91 Bn | 534.44 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 505.47 Bn | 478.59 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.18 Bn | 262.17 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 236.22 Bn | 191.62 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.14 Bn | 116.79 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Keros Therapeutics | 224.54 Mn | -1.70 Bn | - | 20.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.72 Mn |
| Dec 31, 2025 | 22.59 Mn |
| Sep 30, 2025 | 23.48 Mn |
| Jun 30, 2025 | 24.36 Mn |
| Mar 31, 2025 | 25.05 Mn |
| Dec 31, 2024 | 26.99 Mn |
| Sep 30, 2024 | 27.23 Mn |
| Jun 30, 2024 | 22.31 Mn |
| Mar 31, 2024 | 22.69 Mn |
| Dec 31, 2023 | 22.73 Mn |
| Sep 30, 2023 | 21.81 Mn |
| Jun 30, 2023 | 22.00 Mn |
| Mar 31, 2023 | 22.21 Mn |
| Dec 31, 2022 | 21.01 Mn |
| Sep 30, 2022 | 6.68 Mn |
| Jun 30, 2022 | 4.30 Mn |
| Mar 31, 2022 | 3.92 Mn |
| Dec 31, 2021 | 3.81 Mn |
| Sep 30, 2021 | 3.89 Mn |
| Jun 30, 2021 | 2.04 Mn |
API Access
Keros Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();